Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

In this edition of the Huntington's Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinical trials in Huntington's disease.

Citation

Carlos Estevez-Fraga, Sarah J Tabrizi, Edward J Wild. Huntington's Disease Clinical Trials Corner: August 2023. Journal of Huntington's disease. 2023;12(2):169-185

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 37483021

View Full Text